Compounds > farnesol

farnesol and amphotericin b

farnesol has been researched along with amphotericin b in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Prasad, R; Sharma, M1
Brilhante, RS; Castelo-Branco, DS; Cordeiro, RA; Giffoni Leite, JJ; Lima, DT; Monteiro, AJ; Paiva, MA; Rocha, MF; Sidrim, JJ; Teixeira, CE1
Alexander, EL; Antachopoulos, C; Jabra-Rizk, MA; Katragkou, A; McCarthy, M; Meletiadis, J; Petraitis, V; Roilides, E; Walsh, TJ1
Bandeira, TJPG; Brilhante, RSN; Caetano, ÉP; Camargo, ZP; Castelo-Branco, DSCM; Cordeiro, RA; de Lima, RAC; Marques, FJF; Monteiro, AJ; Moreira, JLB; Rocha, MFG; Sidrim, JJC; Silva, NF1
Qian, F; Wei, X; Xia, J; Xu, W; Zhang, Z1
Ahmad, A; Srivastava, V1
Onder, S; Oz, Y1

Other Studies

7 other study(ies) available for farnesol and amphotericin b

ArticleYear
The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Apoptosis; ATP-Binding Cassette Transporters; Biological Transport, Active; Candida albicans; Drug Resistance, Multiple, Fungal; Drug Synergism; Farnesol; Fluconazole; Fungal Proteins; Ketoconazole; Kinetics; Membrane Transport Proteins; Miconazole; Microbial Sensitivity Tests; Quorum Sensing; Reactive Oxygen Species; Rhodamines; Saccharomyces cerevisiae

2011
Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol.
    Medical mycology, 2013, Volume: 51, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Farnesol; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests

2013
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Dose-Response Relationship, Drug; Drug Interactions; Farnesol; Fluconazole; Humans; Microbial Sensitivity Tests; Microscopy, Confocal

2015
Histoplasma capsulatum in planktonic and biofilm forms: in vitro susceptibility to amphotericin B, itraconazole and farnesol.
    Journal of medical microbiology, 2015, Volume: 64, Issue:Pt 4

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Drug Synergism; Farnesol; Histoplasma; Itraconazole; Microbial Sensitivity Tests; Microbial Viability

2015
In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.
    Biofouling, 2017, Volume: 33, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Farnesol; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Naphthalenes; Terbinafine

2017
Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol.
    PloS one, 2020, Volume: 15, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Drug Resistance, Fungal; Farnesol; Fluconazole; Microbial Sensitivity Tests; Quorum Sensing; South Africa

2020
In Vitro Effects of Farnesol Alone and in Combination with Antifungal Drugs Against Aspergillus Clinical Isolates.
    Medical mycology journal, 2021, Volume: 62, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Resistance, Fungal; Drug Synergism; Farnesol; Humans; Voriconazole

2021